Edition:
United States

GenVec Inc (GNVC.OQ)

GNVC.OQ on NASDAQ Stock Exchange Capital Market

6.31USD
27 Mar 2017
Change (% chg)

-- (--)
Prev Close
$6.31
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
61,075
52-wk High
$14.00
52-wk Low
$2.70

GNVC.OQ

Chart for GNVC.OQ

About

GenVec, Inc. (GenVec) is a clinical-stage biopharmaceutical company, engaged in the development of therapeutics and vaccines. The Company designs, tests and manufactures adenoviral-based product candidates. The Company's development programs address therapeutic areas, such as hearing loss and balance disorders, as well as... (more)

Overall

Beta: 3.23
Market Cap(Mil.): $14.98
Shares Outstanding(Mil.): 2.27
Dividend: --
Yield (%): --

Financials

  GNVC.OQ Industry Sector
P/E (TTM): -- 47.76 29.98
EPS (TTM): -2.86 -- --
ROI: -84.92 -2.36 13.08
ROE: -93.45 5.29 14.23

BRIEF-Christopher Brown reports 7.5 pct passive stake in Genvec

* Christopher Brown reports 7.5 percent passive stake in Genvec Inc as of January 24 - sec filing Source text : http://bit.ly/2jRXvBb Further company coverage:

Jan 31 2017

BRIEF-Intrexon to acquire Genvec to expand gene delivery platform

* Intrexon to acquire Genvec to expand industry-leading gene delivery platform

Jan 24 2017

BRIEF-Genvec reports Q3 loss per share $0.05

* For 2016, Genvec continues to anticipate a cash burn between $6.0 million and $6.5 million

Nov 04 2016

More From Around the Web

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $125.80 --
Novartis AG (NOVN.S) CHF73.90 +0.05
Pfizer Inc. (PFE.N) $34.18 --
Bayer AG (BAYGn.DE) €107.50 +0.90
Bayer AG (BAYE.F) -- --
Merck & Co., Inc. (MRK.N) $63.19 --
Sanofi SA (SASY.PA) €83.27 -0.20
AstraZeneca plc (AZN.L) 4,953.50 -21.00
GlaxoSmithKline plc (GSK.L) 1,674.25 -2.75
Bavarian Nordic A/S (BAVA.CO) kr.349.50 +2.00

Earnings vs. Estimates